Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houston Thompson

Showing results (301-310 of 374) with videos related to

Pageof 38
Sort By:
The Journal of Urology|July 30, 2024
Reply by AuthorsAbhinav Khanna, Harrison C Gottlich, Maddy Dorr, et al.
BMC Urology|March 23, 2017
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumorJeanette E Eckel-Passow, Daniel J Serie, John C Cheville, et al.
The Journal of Urology|December 11, 2012
Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologistsSimon P Kim, R Jeffrey Karnes, Paul L Nguyen, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2020
Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomyDavid Y Yang, Theodora A Potretzke, Tanner S Miest, et al.
Human Pathology|November 9, 2020
Renal neoplasia with papillary architecture involving the pelvicalyceal systemSounak Gupta, John C Cheville, Belinda K Galeano, et al.
Urology|August 30, 2024
Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?Ekamjit S Deol, Vidit Sharma, Anthony E Fadel, et al.
Urologic Oncology|July 7, 2020
Long-term outcomes of incidental prostate cancer at radical cystectomyVignesh T Packiam, Matvey Tsivian, Svetlana Avulova, et al.
European Urology|August 11, 2014
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal massesR Houston Thompson, Tom Atwell, Grant Schmit, et al.
BJU International|August 5, 2016
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomesSarah P Psutka, Mark Heidenreich, Stephen A Boorjian, et al.
European Urology|September 27, 2014
Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9R Houston Thompson, Tom Atwell, Grant Schmit, et al.
Pageof 38

Showing results (301-310 of 374) with videos related to

Sort By:
Pageof 38
The Journal of Urology|July 30, 2024
Reply by AuthorsAbhinav Khanna, Harrison C Gottlich, Maddy Dorr, et al.
BMC Urology|March 23, 2017
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumorJeanette E Eckel-Passow, Daniel J Serie, John C Cheville, et al.
The Journal of Urology|December 11, 2012
Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologistsSimon P Kim, R Jeffrey Karnes, Paul L Nguyen, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2020
Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomyDavid Y Yang, Theodora A Potretzke, Tanner S Miest, et al.
Human Pathology|November 9, 2020
Renal neoplasia with papillary architecture involving the pelvicalyceal systemSounak Gupta, John C Cheville, Belinda K Galeano, et al.
Urology|August 30, 2024
Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?Ekamjit S Deol, Vidit Sharma, Anthony E Fadel, et al.
Urologic Oncology|July 7, 2020
Long-term outcomes of incidental prostate cancer at radical cystectomyVignesh T Packiam, Matvey Tsivian, Svetlana Avulova, et al.
European Urology|August 11, 2014
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal massesR Houston Thompson, Tom Atwell, Grant Schmit, et al.
BJU International|August 5, 2016
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomesSarah P Psutka, Mark Heidenreich, Stephen A Boorjian, et al.
European Urology|September 27, 2014
Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9R Houston Thompson, Tom Atwell, Grant Schmit, et al.
Pageof 38